Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)

NCT05736523 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT05736523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05736523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)
Lead sponsor
University of Utah
Phase
Observational
Overall status
Active, not recruiting
Start date
September 23, 2020
Completion date
June 30, 2025
Enrollment
28 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma